글로벌 경막하혈종 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력 : 글로벌 경막하 혈종 치료 시장

경막하 혈종 치료 시장은 2021-2028년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 4.70%의 CAGR로 성장할 것으로 예측하여 시장을 분석합니다.

경막하 혈종은 경막(뇌 덮개)과 뇌 표면 사이에 혈액이 축적되는 것을 특징으로 하는 신경 질환입니다. 이는 외상성 뇌 손상의 한 유형이며 심각한 두부 손상으로 인해 발생합니다. 이 장애의 징후와 증상에는 발작, 행동 변화, 두통 , 메스꺼움, 혼란, 현기증, 구토, 무기력, 무관심, 쇠약 등이 있습니다. 이는 두개내 혈종 또는 경막하 출혈이라고도 합니다.

경막하 혈종의 유병률 증가, 두부 손상의 증가, 알코올 남용은 시장 성장률에 영향을 미치는 주요 요인입니다. 또한, 혈우병 환자의 발생률 증가, 노인 인구 증가, 혈액 응고 방지제 사용 증가, 질병에 대한 인식을 확산하기 위한 정부 및 민간 기관의 이니셔티브 증가는 경막하 혈종 치료 시장을 확대할 요인입니다.

2021~2028년 예측 기간 동안 연구 개발 활동의 증가와 새로운 시장의 출현은 경막하혈종 치료 시장에 유익한 기회를 제공할 것입니다.

그러나 높은 치료 비용과 뇌탈출, 발작, 반복 출혈과 같은 질병과 관련된 합병증은 시장 성장을 방해하는 요인입니다. 예방 조치와 이용 가능한 치료에 대한 인식 부족은 위에서 언급한 예측 기간 동안 경막하 혈종 치료 시장에 더욱 큰 도전이 될 것입니다.

This subdural hematoma treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the subdural hematoma treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Subdural Hematoma Treatment Market Scope and Market Size

The subdural hematoma treatment market is segmented on the basis of type, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the subdural hematoma treatment market is segmented into acute subdural hematoma, subacute subdural hematoma and chronic subdural hematoma.
• On the basis of treatment, the subdural hematoma treatment market is segmented into anticonvulsants, diuretics, corticosteroids, surgery, catheter, physical therapy, speech therapy, vitamin K therapy and others.
• On the basis of diagnosis, the subdural hematoma treatment market is segmented into CT scan, MRI and others.
• On the basis of dosage, the subdural hematoma treatment market is segmented into tablet, injection and others.
• On the basis of route of administration, the subdural hematoma treatment market is segmented into oral, intravenous and others.
• On the basis of symptoms, the subdural hematoma treatment market is segmented into seizures, change in behavior, headache, nausea, confusion, dizziness, vomiting, lethargy, apathy, weakness and others.
• On the basis of end-users, the subdural hematoma treatment market is segmented into clinic, hospital and others.

The subdural hematoma treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Subdural Hematoma Treatment Market Country Level Analysis

The subdural hematoma treatment market is segmented on the basis of type, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel.

The countries covered in the subdural hematoma treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the subdural hematoma treatment market due to the presence of major key players, growing investment for R&D activities, high disposable income, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Subdural hematoma treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Subdural Hematoma Treatment Market Share Analysis

Subdural hematoma treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global subdural hematoma treatment market research.

경막하 혈종 치료 시장 보고서에 포함된 주요 기업으로는 Novartis AG, Sanofi, Pfizer Inc., Johnson & Johnson Private Limited, Abbott, Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB SA, Sunovion Pharmaceuticals Inc., GW Pharmaceuticals plc., AstraZeneca, GlaxoSmithKline plc, H. Lundbeck A/S, Takeda Pharmaceutical Company Limited., Sumitomo Dainippon Pharma Co., Ltd., Biocon, Merck KGaA, Cadila Pharmaceuticals, Eisai Co., Ltd., Cipla Inc., Glenmark Pharmaceuticals Limited, Mankind Pharma, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd., Sun Pharmaceutical Industries Ltd. 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-66807